A Phase 1/2 Trial SRA737 in Combination With Gemcitabine and Cisplatin or Gemcitabine Alone in Advanced Cancer Subjects
Sierra Oncology LLC - a GSK company
Sierra Oncology LLC - a GSK company
Dana-Farber Cancer Institute
Roswell Park Cancer Institute
University of California, San Francisco
Office of Rare Diseases (ORD)